Bacillus Calmette-Guerin therapy for superficial bladder cancer: A 10-year followup Journal Article
| Authors: | Herr, H. W.; Wartinger, D. D.; Fair, W. R.; Oettgen, H. F. |
| Article Title: | Bacillus Calmette-Guerin therapy for superficial bladder cancer: A 10-year followup |
| Abstract: | We report the outcome of 61 patients with superficial bladder tumors who received bacillus Calmette-Guerin (BCG) therapy and were followed for at least 10 years (range 10 to 13 years). A total of 19 patients (31%) remains free of tumor and progression, 17 (28%) had interval superficial recurrences but no progression and 25 (41%) had progression, first identified as muscle invasion in 12, prostatic involvement in 8 or metastasis in 5. Most tumors recurred or progressed within the first 5 years. Of the 61 patients 33 (54%) are disease-free and with an intact bladder, 13 (21%) are alive after cystectomy, 2 (3%) died of other causes, 1 (2%) is alive with metastasis and 12 (20%) died of metastatic urothelial cancer (11 from the bladder or prostate and 1 from an upper tract tumor). |
| Keywords: | adult; aged; middle aged; cancer staging; follow up; follow-up studies; neoplasm staging; bcg vaccine; metastasis; neoplasm recurrence, local; carcinoma, papillary; pathology; bladder tumor; urinary bladder neoplasms; time; time factors; cancer invasion; tumor recurrence; carcinoma in situ; neoplasm invasiveness; papillary carcinoma; multiple cancer; neoplasms, multiple primary; humans; human; male; female; article |
| Journal Title: | Journal of Urology |
| Volume: | 147 |
| Issue: | 4 |
| ISSN: | 0022-5347 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 1992-04-01 |
| Start Page: | 1020 |
| End Page: | 1023 |
| Language: | English |
| DOI: | 10.1016/s0022-5347(17)37452-9 |
| PUBMED: | 1552578 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work